Home
Technical
Publications
Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis(A25022-10.1)

Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis(A25022-10.1)

Date：2026-03-03 Views：22

Prev：Targeted inhibition of NEK7 preventing sepsis-induced cardiomyopathy by inhibiting NLRP3 inflammasome.(KTI1010-4.7)

Next：Targeted inhibition of NEK7 preventing sepsis-induced cardiomyopathy by inhibiting NLRP3 inflammasome.(BMU106-4.7)

RECEIVE OFFERS BY EMAIL

CONTACT US

Welcome any form of communications, and better service will be provided here.

Tell： +1-404-854-0155

Email： service@abbkine.com

Support Email： support@abbkine.com

Address： 3052 Stroop Hill Road, Apt 203, Atlanta 30303, Georgia, United States of America

Links：

Copyright © 2012 - 2017 Abbkine, Inc. - All rights reserved